NewLimit: Capital Raising
NewLimit raised $435M Series C for longevity medicines using epigenetic reprogramming, led by Founders Fund
Source: Crunchbase News
The leadership read
Clinical-stage biotech company will need Chief Medical Officer, VP Clinical Development, VP Regulatory Affairs, and pharmaceutical industry executives to advance pipeline
Market context: the MitchelLake Talent Market Index reads 108.5 — Hot (+10.8 vs prior month); Americas signal share is easing (-9.8pts).
MitchelLake in this thematic
Our work · 2024
Head of Global Revenue Operations
Hero Inc. Limited
EMEA · revenue operations · saas
Our work · 2017
Retained Search
TNS Mobile Oy
EMEA · Professional Services · market research · mobile analytics
Our work · 2016
Experience Design Market Research Project
Isobar
Oceania · Professional Services · digital agency · experience design